Multi-Modal Partnerships

Extensive domain knowledge and connections

Multi-Modal Partnerships

Today’s life science landscape is expanding across more axes than ever. TechBio drug designers are blurring the lines between IT cores and pharma development. Powerful yet secure computing needs are ubiquitous for burgeoning AI & data science efforts.

Strategic partnerships are essential for accelerating growth and achieving ambitious goals. Whether you’re seeking to access in silico drug discovery expertise, or need AI solutions to help  reposition clinical assets for new markets, identifying the right partner can be a game-changer.

At Scientari, we serve as your strategic matchmaker, connecting you with high-value partners across the biotech, pharma, and techbio ecosystem. Our deep industry knowledge and extensive network allow us to pinpoint synergistic collaborations that drive innovation and deliver tangible results.

Going beyond simple introductions, we take the time to understand your unique needs and objectives, meticulously curating a selection of potential partners that align with your vision. We then facilitate meaningful connections, guiding you through the partnership exploration process, from initial discussions to due diligence and negotiation.

With Scientari as your partner, you can confidently navigate the complexities of collaboration, unlocking new opportunities and maximizing your potential for success.

Trusted Partners

We’re building a network of trusted partners with whom we’ve built long-standing relationships

Opus Three Life Sciences supports the pharmaceutical and diagnostic industry to answer questions related to the scientific, regulatory, and business strategy of products and solutions in precision medicine.  Founder Felix Frueh PhD (Linkedin) has twenty-five years of experience setting scientific and corporate strategy in precision medicine. He’s been a senior executive in large organizations, founder of several startup companies, advisor to numerous diagnostics and pharmaceutical companies. Eighteen years of regulatory experience in US, including five years of hands-on work at FDA. Twelve years of experience as Board member or Director of pharmaceutical and diagnostic companies. Contact Dr Frueh at info@opusthree.com

Nanobot Medical offers comprehensive communication planning and solutions, from brand building to web and sales collateral, as well as engaging scientific animations.  

ArchonBio emerges from Stealth

Archon Biosciences emerged from stealth with $20M (Madrona Ventures) in seed funding to develop AI-designed protein “cages” in order to amplify antibody treatments and...

Open Reaction Database (ORD)

AI-driven drug discovery is improved with knowledge of a molecule's synthesis pathway and cost. The Open Reaction Database (ORD) recently received an extensive update...

Human Tumor Atlas Network (Nature)

Nature published the Human Tumor Atlas Network to expand spatial understanding of molecular, cellular and tissue features. HTAN offers a multidimensional view of cancer...

San Diego’s Iambic Therapeutics releases AI platform for better outcome predictions

Iambic's AI-driven Enchant™ platform predicts clinical outcomes better than industry standard—from the discovery stage of drug development. Utilizing early discovery...

Takeaways from Festival of Biologics (San Diego)

April 2024 - Festival of Biologics (Terrapin, San Diego) featured exciting talks on genAI for clinical trials. Here are a few intriguing takeaways: Trial challenges are...